Phathom Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
458
across all filing types
Latest filing
2026-05-21
Regulatory Filings
Country
US
United States of America
Listing
US
PHAT
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for acid-related gastrointestinal (GI) diseases. The company's primary efforts are centered on advancing its lead product candidate, vonoprazan, a potassium-competitive acid blocker (P-CAB). This therapeutic is developed for a range of indications, including the treatment of erosive esophagitis, Helicobacter pylori (H. pylori) infection, and non-erosive reflux disease. Phathom aims to transform the treatment landscape for these conditions by addressing unmet medical needs and improving patient outcomes with innovative therapeutic options.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| 10-Q - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | |
| 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | |
| ARS - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | |
| DEF 14A - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | |
| S-8 - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-03-27 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46753467 | 8-K | 2026-05-21 | English | ||
| 39071239 | 10-Q - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | ||
| 39071212 | 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | ||
| 33707039 | ARS - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | ||
| 33706792 | DEF 14A - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | ||
| 33065545 | S-8 - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-03-27 | English | ||
| 32898205 | 4 - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-03-03 | English | ||
| 32898207 | 10-K - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-02-26 | English | ||
| 32898206 | 8-K - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-02-26 | English | ||
| 31697143 | 4 Filing | 2026-02-12 | English | ||
| 31697060 | 4 Filing | 2026-02-12 | English | ||
| 31697051 | SCHEDULE 13G/A Filing | 2026-01-27 | English | ||
| 31696987 | 4 Filing | 2026-01-27 | English | ||
| 31696930 | 4 Filing | 2026-01-23 | English | ||
| 13192726 | 4 | 2026-01-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biofrontera AG
Biopharmaceutical firm specializing in photodynamic therapy…
|
B8F | DE | Manufacturing |
|
Biofrontera Inc.
A biopharmaceutical company commercializing products for de…
|
BFRI | US | Manufacturing |
|
BioGaia
A healthcare and biotechnology company developing clinicall…
|
BIOG | SE | Manufacturing |
|
BIOGEN INC.
Biotechnology company developing therapies for neurological…
|
BIIB | US | Manufacturing |
|
Bio Green Med Solution, Inc.
A diversified company in the biopharmaceutical and fire saf…
|
BGMS | US | Manufacturing |
|
BIOHARVEST SCIENCES INC.
A biotech firm using a platform to grow plant cells for hea…
|
BHST | CA | Manufacturing |
|
Biohaven Ltd.
Develops therapies for neuroscience, immunology, and oncolo…
|
BHVN | VG | Manufacturing |
|
BioInvent International
Develops novel, first-in-class immuno-modulatory antibodies…
|
BINV | SE | Manufacturing |
|
BIOLIFE SOLUTIONS INC
Manufactures biopreservation media and tools for cell and g…
|
BLFS | US | Manufacturing |
|
BioLineRx Ltd.
A clinical-stage biopharmaceutical company developing thera…
|
BLRX | IL | Manufacturing |
Phathom Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32407/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32407 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32407 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32407 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32407}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Phathom Pharmaceuticals, Inc. (id: 32407)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.